Amyris to Acquire Sweet Protein Developer Oobli

The deal pairs Amyris' fermentation manufacturing scale with Oobli's sweet-protein platform, following capacity expansion at a Brazilian plant.

Amyris, Inc. (Emeryville, Calif.) has announced that it will acquire Oobli Inc. (Davis, Calif.), a developer of fermentation-derived sweet proteins that food and beverage brands use to reduce sugar without sacrificing taste. The company said the transaction is expected to close in the coming weeks.

Amyris describes itself as a vertically integrated biomanufacturing company. It said the acquisition brings its scientific capabilities and manufacturing depth together with Oobli's protein fermentation expertise, and follows the expansion of manufacturing capacity earlier this year at its fermentation facility in Barra Bonita, Brazil. Amyris characterized the move as a strategic commercial and technology expansion intended to accelerate its presence in protein- and peptide-based solutions across end markets.

Complementary technology platforms

Amyris chief executive officer Kathy Fortmann said the company views Oobli as a commercial and technology platform that complements its own. She said Oobli is positioned to change how sweetness reaches the market, and that Amyris intends to bring commercial scale and resources to accelerate that shift. Fortmann added that pairing Oobli's protein expertise with Amyris' strain engineering, manufacturing scale and commercial capabilities could broaden the combined company's reach in food and beverage, personal care, flavors and fragrances, agriculture and other areas.

Oobli's commercial portfolio of sweet proteins is expected to be the first to benefit from the combined platform. According to the announcement, the company has spent the past decade refining a fermentation process for producing sweet proteins that occur naturally in rare fruits and berries grown near the equator.

How sweet proteins work

Amyris says sweet proteins are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors and are metabolized by the body as protein, delivering sweetness without gut disruption or blood sugar spikes. The company describes Oobli's sweet proteins as the first of their kind in the sugar-reduction category.

Oobli's portfolio includes what the companies call Oubli Fruit, Serendipity Berry and Katemfe Fruit sweet proteins, known scientifically as brazzein, monellin and thaumatin. The ingredients hold FDA GRAS status as an ingredient and are FEMA GRAS-affirmed for use as a natural flavor, according to the announcement. Amyris points to growing consumer awareness of metabolic health and the benefits of sugar reduction as the driver of demand across categories ranging from sports nutrition and dairy to beverages, chocolate, bakery and confectionery.

The seller's perspective

Oobli chief executive officer Ali Wing said the company has long believed there was a better way to deliver the sweet taste consumers want without trade-offs to health and the environment, and described its past breakthroughs with pride. She said joining Amyris gives Oobli the scale and resources to pursue its ambition of making sweet proteins a global standard in sweetness solutions.

Fortmann added that biomanufactured solutions succeed when they align with consumer demand and market needs, and said Oobli's platform offers brands a way to address sweet taste, sugar reduction and clean label at the same time. She said Amyris is looking forward to welcoming the Oobli team.

Amyris said all existing customer commitments and brand partnerships will continue to be honored without interruption as Oobli's sweet protein portfolio expands within the company.

SV

Selene Voss

Selene Voss covers basic and industrial chemicals, specialty chemicals, and water treatment chemicals with a focus on safety documentation and strategic sourcing. She compares supplier SDS, COA, purity, water content, flash point, and batch traceability data, while framing GHS and applicable REACH information as jurisdiction-dependent inputs rather than product certifications. Her work supports EHS managers, regulatory affairs teams, plant managers, and industrial buyers who must evaluate dual sourcing, storage boundaries, transport constraints, and total landed cost before qualification.